This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Potera, C. Nat Biotechnol. 25, 497–499 (2007).
O'Brien S. et al. J. Clin. Oncol. 25, 1114–1120 (2007).
Bedikian, A.Y. et al. J. Clin Oncol. 24, 4738–4745 (2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author is one of a number of holders of the original NIH phosphorothioate oligonucleotide patent that was licensed by Genta and others. If Genasense is approved for marketing, he will receive a capped royalty.
Rights and permissions
About this article
Cite this article
Stein, C. The Genasense 'learning curve'. Nat Biotechnol 25, 972–973 (2007). https://doi.org/10.1038/nbt0907-972
Issue Date:
DOI: https://doi.org/10.1038/nbt0907-972